To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene HOMER3andCOPETABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
563 representative clones for gene HOMER3andCOPE back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
CA866514 Pancreas, Purified pancreatic islet .a-u 1 to 385 1 to 385   tiling clone, fully sequenced,   385/385
(100 %)
2 diff
(99.5 %id)
BM012336 brain, neuroblastoma, cell line .a-u 36 to 482 1 to 447       447/449
(99 %)
2 diff
(99.6 %id)
TI_59381547   .a-u 37 to 482 102 to 547       446/448
(99 %)
2 diff
(99.6 %id)
BQ069493 brain, neuroblastoma, cell line .a-u 38 to 845 1 to 810   tiling clone,   810/1032
(78 %)
13 diff
(98.8 %id)
BQ956939 brain, neuroblastoma, cell line .a-u 40 to 780 29 to 775       747/989
(75 %)
22 diff
(97.8 %id)
BU949849 Pancreas, Purified pancreatic islet .a-u 49 to 275 3 to 229   fully sequenced,   227/229
(99 %)
6 diff
(97.4 %id)
CA772618 Pancreas, Purified pancreatic islet .a-u 84 to 459 1 to 375   fully sequenced,   375/375
(100 %)
8 diff
(97.9 %id)
BU949565 Pancreas, Purified pancreatic islet .a-u 245 to 823 579 to 1   fully sequenced,   579/579
(100 %)
2 diff
(99.7 %id)
CA866783 Pancreas, Purified pancreatic islet .a-u 355 to 823 469 to 1   fully sequenced,   469/469
(100 %)
4 diff
(99.2 %id)
AI654031 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a-u 404 to 826 423 to 1   tiling clone,   423/423
(100 %)
2 diff
(99.6 %id)
CA771772 Pancreas, Purified pancreatic islet .a-u 429 to 825 396 to 1   fully sequenced,   396/396
(100 %)
7 diff
(98.3 %id)
BF819752 kidney_tumor .a-u 497 to 940 1 to 446   tiling clone,   446/446
(100 %)
12 diff
(97.4 %id)
DB138926 thymus .a-u 825 to 1331 2 to 508   tiling clone, capped   507/507
(100 %)
1 diff
(99.9 %id)
AU133735 ovary, tumor tissue .a-u 889 to 1536 2 to 650   tiling clone, to resequence, capped   649/649
(100 %)
8 diff
(98.8 %id)
BQ010354 Chondrosarcoma, Left Pubic Bone .a-u 2258 to 2761 520 to 17   tiling clone, AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 504/508
(99 %)
0 diff
(100 %id)
AU154957 ovary, tumor tissue .a-u 2337 to 2761 429 to 1   to resequence,   429/429
(100 %)
12 diff
(97.3 %id)
BE774326 uterus .a-u 2425 to 2624 220 to 22       199/220
(90 %)
0 diff
(100 %id)
AI382616 B-cell, chronic lymphotic leukemia .a-u 2490 to 2762 274 to 1   tiling clone,   274/274
(100 %)
1 diff
(99.7 %id)
AI382603 B-cell, chronic lymphotic leukemia .a-u 2537 to 2762 226 to 1       226/226
(100 %)
1 diff
(99.6 %id)
BU165112 eye, retinoblastoma .b 1 to 824 11 to 834   tiling clone,   824/873
(94 %)
15 diff
(98.3 %id)
BM808238 ovary (pool of 3) .b 2 to 542 63 to 604       542/1304
(41 %)
9 diff
(99.4 %id)
BF526706 brain, glioblastoma with EGFR amplification .b 6 to 666 9 to 680       672/847
(79 %)
31 diff
(96.4 %id)
BM811222 ovary (pool of 3) .b 8 to 674 17 to 687       671/1138
(58 %)
29 diff
(97.5 %id)
CN284190 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 9 to 619 9 to 618   tiling clone,   610/618
(98 %)
9 diff
(98.6 %id)
CX753860 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 14 to 757 1 to 733     Submitted on the opposite strand 733/850
(86 %)
16 diff
(98.2 %id)
CN284193 embryonic stem cells, DMSO-treated H9 cellline .b 18 to 581 1 to 564       564/564
(100 %)
1 diff
(99.9 %id)
BG119617 adenocarcinoma, cell line, Liver .b 19 to 748 1 to 728       728/882
(82 %)
16 diff
(98.2 %id)
CB129765 Liver .b 21 to 603 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
CB138327 Liver .b 23 to 452 1 to 430       430/430
(100 %)
4 diff
(99.1 %id)
CN284187 embryonic stem cells, cell lines H1, H7, andH9 .b 31 to 643 1 to 613       613/613
(100 %)
1 diff
(99.9 %id)
BI085101 astrocytoma grade IV, cell line, brain .b 31 to 756 1 to 727   tiling clone, fully sequenced,   727/727
(100 %)
13 diff
(98.3 %id)
BI085742 astrocytoma grade IV, cell line, brain .b 726 to 1405 685 to 3   tiling clone, fully sequenced,   683/685
(99 %)
8 diff
(98.9 %id)
AK313995 cerebellum .c 1 to 1608 1 to 1608 S342R tiling clone,   1608/1608
(100 %)
4 diff
(99.8 %id)
DA624254 Kidney .c 1 to 546 2 to 547   tiling clone, capped   546/546
(100 %)
1 diff
(99.9 %id)
DA054541 cerebellum .c 2 to 570 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
DA260516 caudate nucleus .c 2 to 564 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
NM_001145722.1   .c 2 to 1850 1 to 1849 exact RefSeq, AAA   1849/1849
(100 %)
0 diff
(100 %id)
DA477332   .c 12 to 568 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA059982 cerebellum .c 305 to 876 2 to 573   capped   572/572
(100 %)
2 diff
(99.7 %id)
DA299920 hippocampus .d 1 to 587 2 to 588   tiling clone, capped   587/587
(100 %)
0 diff
(100 %id)
AK124450 cerebellum .d 109 to 2087 1 to 1979 S342R available from FLJ,   1979/1979
(100 %)
3 diff
(99.9 %id)
NR_027297.1   .d 109 to 2089 1 to 1981 exact RefSeq, tiling clone, AAA   1981/1981
(100 %)
0 diff
(100 %id)
DA068597 cerebellum .d 110 to 678 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
CN412391 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 180 to 772 1 to 594       594/594
(100 %)
2 diff
(99.7 %id)
BF876185 lung_tumor .d 583 to 893 308 to 1     Submitted on the opposite strand 308/308
(100 %)
5 diff
(98.4 %id)
DB297402 cerebellum .d 1561 to 2087 527 to 1       527/527
(100 %)
2 diff
(99.7 %id)
BX459274 placenta .e 1 to 1014 1 to 1013       1013/1022
(99 %)
12 diff
(98.9 %id)
BX387612 Placenta Cot 25-normalized .e 1 to 950 33 to 983   tiling clone,   951/1086
(87 %)
16 diff
(98.6 %id)
NM_004838.3   .e 2 to 1578 1 to 1577 exact RefSeq, AAA   1577/1577
(100 %)
0 diff
(100 %id)
DA007130   .e 11 to 399 2 to 390   tiling clone, capped   389/389
(100 %)
0 diff
(100 %id)
BG715590 brain, hypothalamus .e 14 to 779 1 to 765       765/765
(100 %)
7 diff
(99.1 %id)
BX383273.
matches multiple genes
  .e 16 to 934 1 to 919     also hits gene WDR77andOVGP1 919/919
(100 %)
10 diff
(99.0 %id)
AL533197 adult brain, brain .e 17 to 814 1 to 800   fully sequenced,   800/800
(100 %)
6 diff
(99.3 %id)
CR601631 Neuroblastoma Cot 10-normalized .e 18 to 1545 1 to 1528 exact     1528/1528
(100 %)
0 diff
(100 %id)
CR618184 adult brain .e 18 to 1534 1 to 1517 exact     1517/1517
(100 %)
0 diff
(100 %id)
AL519562 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .e 18 to 814 1 to 797   fully sequenced,   797/797
(100 %)
5 diff
(99.4 %id)
DB500973 hypothalamus .e 19 to 512 1 to 494       494/494
(100 %)
4 diff
(99.2 %id)
CR604813 HeLa cells Cot 25-normalized .e 20 to 1557 1 to 1538 exact     1538/1538
(100 %)
0 diff
(100 %id)
BX384610   .e 20 to 866 1 to 847   fully sequenced,   847/847
(100 %)
5 diff
(99.5 %id)
BQ066993 brain .e 25 to 784 10 to 784       775/1121
(69 %)
28 diff
(97.6 %id)
TI_57152779   .e 26 to 772 26 to 772       747/772
(96 %)
16 diff
(98.0 %id)
CR626845 Placenta Cot 25-normalized .e 31 to 1547 1 to 1517 exact     1517/1517
(100 %)
0 diff
(100 %id)
AL551009 placenta, Placenta Cot 25-normalized .e 31 to 814 1 to 787   fully sequenced,   787/787
(100 %)
7 diff
(99.2 %id)
BI764673 pooled colon, kidney, stomach .e 31 to 772 1 to 742       742/742
(100 %)
5 diff
(99.4 %id)
DA646077 mammary gland .e 32 to 790 2 to 754   capped   753/797
(94 %)
15 diff
(98.2 %id)
CB216343 normal endometrium, mid-secretory phase,cycle day 23, uterus .e 34 to 119 1 to 86       86/86
(100 %)
1 diff
(98.9 %id)
DT218465 brain .e 35 to 650 1 to 616       616/616
(100 %)
2 diff
(99.7 %id)
BI916260 brain .e 35 to 863 1 to 827       827/832
(99 %)
8 diff
(99.1 %id)
TI_57239786   .e 35 to 863 70 to 896       827/901
(91 %)
13 diff
(98.6 %id)
CR617622 Placenta Cot 25-normalized .e 41 to 1548 1 to 1508 exact     1508/1508
(100 %)
0 diff
(100 %id)
AL543131 placenta, Placenta Cot 25-normalized .e 41 to 793 1 to 753   fully sequenced,   753/753
(100 %)
6 diff
(99.3 %id)
BM922587 leukocyte .e 41 to 548 62 to 572       511/1161
(44 %)
11 diff
(99.1 %id)
BQ712420 Spleen .e 41 to 940 18 to 918       901/980
(91 %)
30 diff
(97.0 %id)
BQ711991 Spleen .e 42 to 545 1 to 507       507/1092
(46 %)
17 diff
(98.5 %id)
DR007035 Spleen .e 42 to 764 1 to 723       723/723
(100 %)
2 diff
(99.8 %id)
BU195711 leiomyosarcoma, uterus .e 44 to 784 1 to 746       746/904
(82 %)
24 diff
(97.4 %id)
CN284194 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .e 45 to 370 1 to 327       327/327
(100 %)
2 diff
(99.4 %id)
CR604554 Neuroblastoma Cot 50-normalized .e 45 to 1559 1 to 1515 exact tiling clone,   1515/1515
(100 %)
0 diff
(100 %id)
AL529052 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .e 45 to 857 1 to 815   fully sequenced,   815/815
(100 %)
6 diff
(99.3 %id)
CB126182 Liver .e 46 to 565 1 to 520       520/520
(100 %)
1 diff
(99.9 %id)
CD671283 eye, Iris .e 47 to 619 1 to 573       573/573
(100 %)
1 diff
(99.9 %id)
CR749099 large cell carcinoma, lung .e 48 to 509 10 to 471       462/471
(98 %)
6 diff
(98.8 %id)
BX393497 Neuroblastoma Cot 10-normalized .e 48 to 619 1 to 576   fully sequenced,   576/576
(100 %)
26 diff
(95.5 %id)
BM544759 brain, hippocampus .e 48 to 668 76 to 695       620/1188
(52 %)
27 diff
(97.8 %id)
BE387014 melanotic melanoma, skin .e 49 to 607 145 to 706       562/707
(79 %)
8 diff
(98.9 %id)
BG768455 melanotic melanoma, high MDR (cell line), skin .e 49 to 869 1 to 828       826/829
(99 %)
30 diff
(96.4 %id)
BI912288 leukocyte .e 50 to 805 1 to 764       764/764
(100 %)
29 diff
(96.3 %id)
BQ216808 large cell carcinoma, lung .e 50 to 662 1 to 624       624/805
(77 %)
13 diff
(98.4 %id)
TI_57235753   .e 50 to 805 1 to 764       764/764
(100 %)
29 diff
(96.3 %id)
BQ709508 Spleen .e 51 to 885 1 to 843       843/919
(91 %)
26 diff
(97.2 %id)
BU957465 adenocarcinoma, cell line, breast .e 52 to 663 1 to 615       615/968
(63 %)
16 diff
(98.4 %id)
BI822397 pooled brain, lung, testis .e 53 to 866 1 to 810       810/810
(100 %)
11 diff
(98.7 %id)
BI837890 pooled pancreas and spleen .e 53 to 999 1 to 937       937/937
(100 %)
22 diff
(97.7 %id)
TI_57200318   .e 53 to 866 65 to 874       810/874
(92 %)
15 diff
(98.3 %id)
TI_57163329   .e 53 to 999 34 to 970       937/970
(96 %)
28 diff
(97.2 %id)
TI_151784243   .e 56 to 663 60 to 670       543/998
(54 %)
52 diff
(94.8 %id)
BG707894 brain, hypothalamus .e 59 to 683 1 to 623       623/623
(100 %)
5 diff
(99.2 %id)
BC012113 Uterus, leiomyosarcoma .e 60 to 1576 1 to 1517 S342R tiling clone, available from MGC, AAA   1517/1517
(100 %)
2 diff
(99.9 %id)
BM728703 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .e 60 to 652 1 to 592       592/592
(100 %)
1 diff
(99.9 %id)
BM922532 leukocyte .e 64 to 940 14 to 895       882/1174
(75 %)
48 diff
(96.0 %id)
DB500396 hypothalamus .e 67 to 553 1 to 487       487/489
(99 %)
2 diff
(99.6 %id)
CA942755 Pancreas, Purified pancreatic islet .e 70 to 655 1 to 586     Submitted on the opposite strand 586/586
(100 %)
1 diff
(99.9 %id)
BU521424 leiomyosarcoma, uterus .e 74 to 928 1 to 860       860/891
(96 %)
16 diff
(98.3 %id)
TI_57220121   .e 75 to 1040 24 to 985       962/1020
(94 %)
34 diff
(96.7 %id)
BI756872 brain .e 81 to 1040 1 to 956       956/991
(96 %)
28 diff
(97.2 %id)
BG167311 hypernephroma, cell line, Kidney .e 104 to 784 1 to 678       678/1065
(63 %)
19 diff
(98.3 %id)
CB114471 Liver .e 112 to 578 1 to 467       467/467
(100 %)
1 diff
(99.8 %id)
CB120076 Liver .e 112 to 553 1 to 442       442/449
(98 %)
4 diff
(99.2 %id)
CB125311 Liver .e 112 to 714 1 to 603       603/603
(100 %)
3 diff
(99.6 %id)
CB124956 Liver .e 112 to 747 1 to 636       636/636
(100 %)
2 diff
(99.7 %id)
CB124650 Liver .e 112 to 686 1 to 575       575/575
(100 %)
3 diff
(99.5 %id)
CB124664 Liver .e 112 to 652 1 to 541       541/541
(100 %)
2 diff
(99.7 %id)
CB125198 Liver .e 112 to 747 1 to 636       636/636
(100 %)
2 diff
(99.7 %id)
CB125386 Liver .e 112 to 611 1 to 500       500/500
(100 %)
2 diff
(99.6 %id)
CB125066 Liver .e 112 to 720 1 to 609       609/609
(100 %)
2 diff
(99.7 %id)
CB125086 Liver .e 112 to 740 1 to 629       629/629
(100 %)
2 diff
(99.7 %id)
CB126693 Liver .e 112 to 546 1 to 436       436/436
(100 %)
4 diff
(99.1 %id)
CB126892 Liver .e 112 to 310 1 to 199       199/199
(100 %)
7 diff
(96.5 %id)
CB126759 Liver .e 112 to 553 1 to 443       443/450
(98 %)
5 diff
(98.9 %id)
CB125942 Liver .e 112 to 663 1 to 552       552/559
(98 %)
4 diff
(99.3 %id)
CB125617 Liver .e 112 to 657 1 to 546       546/546
(100 %)
2 diff
(99.7 %id)
BM922300 pooled brain, lung, testis .e 115 to 943 1 to 831       831/1021
(81 %)
10 diff
(99.1 %id)
BI755028 brain .e 116 to 999 1 to 884       884/884
(100 %)
16 diff
(98.2 %id)
TI_57216167   .e 116 to 999 35 to 918       884/918
(96 %)
22 diff
(97.7 %id)
DA897929 skeletal muscle .e 126 to 593 93 to 560   capped   468/559
(83 %)
4 diff
(99.3 %id)
BM547704 brain, hippocampus .e 131 to 951 1 to 820       820/1078
(76 %)
13 diff
(98.8 %id)
BM511218 insulinoma, Pancreas .e 178 to 760 1 to 583       583/583
(100 %)
6 diff
(99.0 %id)
CK823814 insulinoma, Pancreas .e 178 to 754 1 to 577       577/577
(100 %)
5 diff
(99.2 %id)
TI_57168492   .e 178 to 943 29 to 797       770/847
(90 %)
26 diff
(97.0 %id)
BI832944 pooled pancreas and spleen .e 184 to 990 1 to 807       807/810
(99 %)
24 diff
(97.1 %id)
CN284191 embryonic stem cells, cell lines H1, H7, andH9 .e 197 to 757 1 to 561       561/561
(100 %)
1 diff
(99.9 %id)
BE788227 large cell carcinoma, lung .e 211 to 792 1 to 577       577/781
(73 %)
21 diff
(97.4 %id)
TI_159676917   .e 219 to 1012 57 to 847       791/1100
(71 %)
22 diff
(98.0 %id)
BT019464   .e 251 to 1334 1 to 1084       1084/1086
(99 %)
3 diff
(99.8 %id)
CV028574 mixed .e 251 to 768 1 to 518       518/518
(100 %)
7 diff
(98.7 %id)
ES313011 beard hair, skin .e 251 to 411 1 to 160       160/160
(100 %)
7 diff
(95.7 %id)
TI_1948085446   .e 251 to 943 131 to 823       693/1401
(49 %)
20 diff
(98.6 %id)
Y17573   .e 251 to 1336 1 to 1086 S342R     1086/1086
(100 %)
1 diff
(100.0 %id)
AW381338 head_neck .e 296 to 505 1 to 209       209/209
(100 %)
1 diff
(99.6 %id)
BM910868 astrocytoma grade IV, cell line, brain .e 299 to 939 1 to 641       641/1072
(59 %)
8 diff
(99.3 %id)
CF132619 Chondrosarcoma Lung Metastasis cell lines, lung .e 300 to 848 1 to 549       549/549
(100 %)
0 diff
(100 %id)
BF350383 head_neck .e 301 to 509 210 to 1       210/210
(100 %)
4 diff
(98.1 %id)
BU957612 adenocarcinoma, cell line, breast .e 341 to 872 1 to 535       535/1017
(52 %)
13 diff
(98.8 %id)
CB126394 Liver .e 366 to 553 1 to 188       188/190
(98 %)
3 diff
(98.5 %id)
BG325413 Kidney, renal cell adenocarcinoma .e 422 to 1090 1 to 665       665/668
(99 %)
6 diff
(99.2 %id)
BM718412 eye, fetal eye .e 434 to 1088 1 to 655   fully sequenced,   655/655
(100 %)
0 diff
(100 %id)
BI193096 epithelioid carcinoma cell line, Pancreas .e 439 to 1246 1 to 809       809/809
(100 %)
4 diff
(99.6 %id)
BG681980 skin, squamous cell carcinoma .e 446 to 1112 1 to 667       667/669
(99 %)
1 diff
(99.9 %id)
BI258491 cervical carcinoma cell line, cervix .e 457 to 1201 1 to 751       749/752
(99 %)
15 diff
(98.1 %id)
BE273828 Kidney, renal cell adenocarcinoma .e 493 to 999 1 to 508       508/508
(100 %)
3 diff
(99.5 %id)
BG682277 skin, squamous cell carcinoma .e 521 to 1328 1 to 804       804/807
(99 %)
7 diff
(99.2 %id)
BG251184 adenocarcinoma, cell line, Liver .e 539 to 1169 1 to 627       627/629
(99 %)
5 diff
(99.3 %id)
BM911224 astrocytoma grade IV, cell line, brain .e 563 to 997 1 to 437       437/1175
(37 %)
12 diff
(99.0 %id)
BG743298 skin .e 569 to 1335 1 to 768       768/768
(100 %)
5 diff
(99.4 %id)
BX393496 Neuroblastoma Cot 10-normalized .e 589 to 1549 951 to 1   fully sequenced,   951/951
(100 %)
24 diff
(97.5 %id)
CB594497 Blood, promyelocytic leukemia .e 611 to 1434 1 to 840       840/865
(97 %)
25 diff
(97.2 %id)
BG283104 adenocarcinoma, cell line, Prostate .e 626 to 1084 1 to 459       459/459
(100 %)
1 diff
(99.8 %id)
BU520777 leiomyosarcoma, uterus .e 664 to 1430 1 to 770       770/841
(91 %)
13 diff
(98.5 %id)
CN284195 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 672 to 1224 9 to 562       554/562
(98 %)
7 diff
(98.8 %id)
CN284189 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .e 682 to 1009 1 to 328       328/328
(100 %)
2 diff
(99.4 %id)
BQ950684 large cell carcinoma, lung .e 718 to 1577 1 to 862       862/905
(95 %)
8 diff
(99.2 %id)
BU526603 epidermoid carcinoma, cell line, lung .e 719 to 1515 1 to 824       824/1022
(80 %)
43 diff
(95.8 %id)
BM010918 brain, neuroblastoma, cell line .e 723 to 1520 1 to 806       806/966
(83 %)
28 diff
(97.2 %id)
TI_59379804   .e 724 to 1520 97 to 901       805/965
(83 %)
27 diff
(97.3 %id)
TI_149308899   .e 752 to 1576 898 to 85   AAA   814/949
(85 %)
11 diff
(98.9 %id)
AL561789 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .e 753 to 1515 789 to 29   fully sequenced,   761/789
(96 %)
7 diff
(99.2 %id)
AL569784 placenta, Placenta Cot 25-normalized .e 753 to 1548 794 to 1   fully sequenced,   794/794
(100 %)
7 diff
(99.2 %id)
AL574820 placenta, Placenta Cot 25-normalized .e 753 to 1547 801 to 1   fully sequenced,   801/801
(100 %)
20 diff
(97.6 %id)
AL565035 adult brain, brain .e 753 to 1534 781 to 1   fully sequenced,   781/781
(100 %)
11 diff
(98.6 %id)
AL162098 uterus .e 755 to 1088 1 to 334   fully sequenced,   334/334
(100 %)
0 diff
(100 %id)
BX102949 senescent fibroblast .e 771 to 1213 1 to 443       443/443
(100 %)
0 diff
(100 %id)
W42820 senescent fibroblast .e 771 to 1086 1 to 312   fully sequenced,   310/310
(100 %)
14 diff
(95.5 %id)
TI_149311618   .e 773 to 1576 887 to 88   AAA   800/956
(83 %)
11 diff
(98.9 %id)
TI_227714654   .e 773 to 1576 882 to 84   AAA   799/987
(80 %)
10 diff
(99.0 %id)
TI_149310795   .e 777 to 1576 889 to 93   AAA   797/936
(85 %)
15 diff
(98.4 %id)
TI_149299124   .e 779 to 1576 877 to 88   AAA   790/796
(99 %)
25 diff
(96.9 %id)
TI_227714678   .e 795 to 1576 881 to 90   AAA   792/1025
(77 %)
85 diff
(91.8 %id)
BE909159 epithelioid carcinoma, Pancreas .e 811 to 1064 1 to 254       254/254
(100 %)
0 diff
(100 %id)
AL563328 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .e 827 to 1546 727 to 13   fully sequenced,   715/727
(98 %)
7 diff
(99.1 %id)
BX352542   .e 836 to 1534 714 to 21   fully sequenced,   694/714
(97 %)
11 diff
(98.5 %id)
BM847284 myeloma .e 845 to 1419 1 to 574       574/574
(100 %)
3 diff
(99.5 %id)
AI741459 pooled .e 847 to 1576 739 to 12   AAA   728/757
(96 %)
27 diff
(96.5 %id)
TI_154124889   .e 852 to 1576 812 to 92   AAA   721/922
(78 %)
7 diff
(99.3 %id)
BM977418 lung, Primary Lung Cystic Fibrosis EpithelialCells .e 862 to 1576 733 to 19   AAA   715/715
(100 %)
1 diff
(99.9 %id)
TI_149285744   .e 870 to 1576 792 to 85   AAA   708/708
(100 %)
2 diff
(99.8 %id)
CD365303 Alveolar Macrophage, lung .e 871 to 1576 724 to 19   AAA   706/706
(100 %)
1 diff
(99.9 %id)
CA415914 Chondrosarcoma Cell line .e 876 to 1576 717 to 19   AAA   699/700
(99 %)
5 diff
(99.3 %id)
BU689063 lung .e 877 to 1576 719 to 19   AAA   701/701
(100 %)
3 diff
(99.6 %id)
BU742632 eye, fetal eye .e 877 to 1576 719 to 19   AAA   701/701
(100 %)
2 diff
(99.8 %id)
CA422849 cell lines, Chondrosarcoma .e 877 to 1576 720 to 19   AAA   702/702
(100 %)
3 diff
(99.6 %id)
CA310356 Alveolar Macrophage, lung .e 877 to 1576 715 to 16   AAA   700/700
(100 %)
1 diff
(99.9 %id)
BU687342 lung .e 878 to 1576 717 to 19   AAA   699/699
(100 %)
1 diff
(99.9 %id)
BQ446944 Knee, Osteoarthritic Cartilage .e 878 to 1576 717 to 19   AAA   699/699
(100 %)
1 diff
(99.9 %id)
BQ773873 Chondrosarcoma Grade II, Left Pelvis .e 878 to 1576 717 to 19   AAA   699/699
(100 %)
1 diff
(99.9 %id)
CA424709 cell lines, Chondrosarcoma .e 878 to 1576 717 to 19   AAA   696/699
(99 %)
6 diff
(99.2 %id)
CA421826 Bone, Enchondroma cell line .e 878 to 1576 717 to 19   AAA   699/699
(100 %)
1 diff
(99.9 %id)
CD743098 Alveolar Macrophage, lung .e 886 to 1576 709 to 19   AAA   691/691
(100 %)
1 diff
(99.9 %id)
BM971633 lung .e 891 to 1576 705 to 19   AAA   687/687
(100 %)
2 diff
(99.8 %id)
CN284188 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .e 912 to 1576 1 to 665       665/673
(98 %)
6 diff
(99.2 %id)
AW026254 brain, glioblastoma (pooled) .e 940 to 1576 631 to 1       631/795
(79 %)
7 diff
(99.2 %id)
BQ003803 Chondrosarcoma, Left Pelvis .e 947 to 1576 648 to 19   AAA   630/630
(100 %)
2 diff
(99.7 %id)
BQ447362 Knee, Osteoarthritic Cartilage .e 947 to 1576 651 to 19   AAA   633/633
(100 %)
4 diff
(99.4 %id)
BX352274   .e 948 to 1572 632 to 1       632/640
(98 %)
31 diff
(95.2 %id)
AW337977 adenocarcinoma, Pancreas .e 951 to 1306 356 to 1       356/357
(99 %)
2 diff
(99.5 %id)
BX387611 Placenta Cot 25-normalized .e 953 to 1540 587 to 1       587/656
(89 %)
13 diff
(98.1 %id)
CK823813 insulinoma, Pancreas .e 977 to 1467 491 to 1       491/491
(100 %)
2 diff
(99.6 %id)
CA942993 Pancreas, Purified pancreatic islet .e 980 to 1576 624 to 28     Submitted on the opposite strand 597/624
(95 %)
0 diff
(100 %id)
CB243058 Human Lung Epithelial cells, lung .e 983 to 1576 612 to 19   AAA   594/594
(100 %)
1 diff
(99.9 %id)
BM510957 insulinoma, Pancreas .e 984 to 1576 609 to 17   AAA   593/597
(99 %)
2 diff
(99.7 %id)
BI254947 cervical carcinoma cell line, cervix .e 998 to 1576 582 to 1     Submitted on the opposite strand 582/584
(99 %)
9 diff
(98.5 %id)
BU541845 carcinoma, cell line, Prostate .e 1008 to 1576 31 to 599   AAA   569/599
(94 %)
7 diff
(98.9 %id)
BM046204 carcinoma, cell line, Prostate .e 1010 to 1576 1 to 566       566/766
(73 %)
5 diff
(99.4 %id)
CN284192 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 1011 to 1576 1 to 566       566/569
(99 %)
3 diff
(99.5 %id)
BQ937057 carcinoma, cell line, Prostate .e 1012 to 1576 1 to 566       566/592
(95 %)
11 diff
(98.2 %id)
BU543055 carcinoma, cell line, Prostate .e 1012 to 1576 1 to 565   AAA   565/565
(100 %)
1 diff
(99.9 %id)
BU552452 carcinoma, cell line, Prostate .e 1012 to 1576 1 to 565   AAA   565/565
(100 %)
1 diff
(99.9 %id)
AL162099 uterus .e 1027 to 1576 566 to 18   fully sequenced, AAA   549/549
(100 %)
1 diff
(99.9 %id)
BM683468 eye, fetal eye .e 1027 to 1576 568 to 19   fully sequenced, AAA   550/550
(100 %)
1 diff
(99.9 %id)
BF593659 brain, glioblastoma (pooled) .e 1028 to 1576 553 to 4       550/553
(99 %)
3 diff
(99.5 %id)
W42730 senescent fibroblast .e 1043 to 1427 382 to 2   fully sequenced,   381/382
(99 %)
3 diff
(99.3 %id)
BM975591 lung, Primary Lung Cystic Fibrosis EpithelialCells .e 1045 to 1576 550 to 19   AAA   532/532
(100 %)
3 diff
(99.5 %id)
TI_227714954   .e 1056 to 1576 606 to 88   AAA   519/765
(67 %)
9 diff
(98.9 %id)
AA127702 uterus .e 1062 to 1557 1 to 493   fully sequenced,   493/493
(100 %)
13 diff
(97.4 %id)
AI924005 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .e 1070 to 1306 237 to 1       237/237
(100 %)
1 diff
(99.6 %id)
CD671282 eye, Iris .e 1073 to 1576 520 to 17   AAA   504/504
(100 %)
4 diff
(99.3 %id)
AA983362 Kidney, kidney tumor .e 1097 to 1547 447 to 1       447/447
(100 %)
9 diff
(98.0 %id)
AA121538 uterus .e 1114 to 1576 461 to 1   fully sequenced,   461/461
(100 %)
9 diff
(98.1 %id)
DB360710 mammary gland .e 1223 to 1576 355 to 1       355/356
(99 %)
5 diff
(98.6 %id)
TI_57229535   .f 1 to 772 87 to 858   tiling clone,   772/772
(100 %)
7 diff
(99.1 %id)
BI870605 adenocarcinoma, cell line, Liver .f 3 to 772 1 to 770   tiling clone,   770/770
(100 %)
7 diff
(99.1 %id)
AW606962 head_neck .f 417 to 651 235 to 1       235/235
(100 %)
0 diff
(100 %id)
AW606963 head_neck .f 417 to 651 1 to 235       235/235
(100 %)
1 diff
(99.6 %id)
AW606967 head_neck .f 417 to 651 236 to 1       236/236
(100 %)
3 diff
(98.8 %id)
BF351048 head_neck .f 417 to 586 172 to 3       170/172
(98 %)
1 diff
(99.5 %id)
NM_001145721.1   .f 417 to 1834 1 to 1418 exact RefSeq, AAA   1418/1418
(100 %)
0 diff
(100 %id)
AF093265 brain .f 433 to 1832 8 to 1407 exact tiling clone, AAA   1400/1407
(99 %)
7 diff
(99.6 %id)
CR594651 Neuroblastoma Cot 25-normalized .g 1 to 1144 1 to 1144 exact tiling clone,   1144/1144
(100 %)
0 diff
(100 %id)
AL523498 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .g 1 to 867 1 to 866   fully sequenced,   866/866
(100 %)
6 diff
(99.4 %id)
BP306882   .g 11 to 563 1 to 551       551/551
(100 %)
3 diff
(99.5 %id)
TI_227712406   .g 234 to 1192 1036 to 89   AAA   948/1015
(93 %)
24 diff
(97.7 %id)
CD367116 Alveolar Macrophage, lung .g 454 to 1192 753 to 19   tiling clone, AAA   735/735
(100 %)
3 diff
(99.6 %id)
AL562214 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .g 806 to 1111 306 to 1   fully sequenced,   306/306
(100 %)
8 diff
(97.4 %id)
NM_001145724.1   .h 1 to 1287 1 to 1287 exact RefSeq, AAA   1287/1287
(100 %)
0 diff
(100 %id)
Y18894   .h 68 to 1049 1 to 982 S306R tiling clone,   982/982
(100 %)
1 diff
(99.9 %id)
CB146787 Liver .i 1 to 475 1 to 477   tiling clone,   477/477
(100 %)
2 diff
(99.6 %id)
CR592877 Placenta Cot 25-normalized .i 73 to 1213 1 to 1141 exact tiling clone,   1141/1141
(100 %)
0 diff
(100 %id)
BM762141 myeloma .i 73 to 588 1 to 516       516/516
(100 %)
0 diff
(100 %id)
NM_007263.3   .i 80 to 1213 1 to 1134 exact RefSeq,   1134/1134
(100 %)
0 diff
(100 %id)
CB141977 Liver .i 81 to 461 1 to 381       381/381
(100 %)
0 diff
(100 %id)
AF092438   .i 82 to 1212 1 to 1126 G7A P8G A9L S10R G12S ... AAA   1126/1126
(100 %)
12 diff
(99.0 %id)
BP196914 adrenal gland .i 83 to 664 1 to 582       582/582
(100 %)
0 diff
(100 %id)
AK222584 coronary artery .i 83 to 1212 1 to 1130 G248C tiling clone, AAA   1130/1130
(100 %)
1 diff
(100.0 %id)
AK315281 testis .i 83 to 1048 1 to 966 T117I     966/966
(100 %)
1 diff
(99.9 %id)
AU098435   .i 83 to 382 1 to 300       300/300
(100 %)
0 diff
(100 %id)
AU102629   .i 83 to 132 1 to 50       50/50
(100 %)
0 diff
(100 %id)
BP215477 corpus callosum .i 83 to 663 1 to 581       581/581
(100 %)
0 diff
(100 %id)
CB129983 Liver .i 83 to 638 1 to 556       556/556
(100 %)
0 diff
(100 %id)
BM834497 stomach .i 83 to 688 1 to 606       606/606
(100 %)
0 diff
(100 %id)
BM789609 stomach .i 83 to 600 1 to 518       518/518
(100 %)
0 diff
(100 %id)
BM794550 stomach .i 83 to 638 1 to 556       556/556
(100 %)
0 diff
(100 %id)
BI826413 brain, medulla .i 84 to 946 1 to 862       862/863
(99 %)
4 diff
(99.6 %id)
DA737805   .i 84 to 803 2 to 722   fully sequenced, capped   721/721
(100 %)
1 diff
(99.9 %id)
CB111338 Liver .i 85 to 618 1 to 534       534/534
(100 %)
0 diff
(100 %id)
CB141846 Liver .i 85 to 637 1 to 553       553/553
(100 %)
0 diff
(100 %id)
DA099387 cerebellum .i 86 to 628 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
CR618263 Placenta Cot 25-normalized .i 86 to 1155 1 to 1070 exact     1070/1070
(100 %)
0 diff
(100 %id)
DA571571 whole embryo, mainly head .i 86 to 788 2 to 710   fully sequenced, capped   709/709
(100 %)
2 diff
(99.8 %id)
DB257816 uterus .i 86 to 652 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
BM784770 Ascites, stomach .i 87 to 470 1 to 384       384/384
(100 %)
0 diff
(100 %id)
BM769590 stomach .i 88 to 577 1 to 490       490/490
(100 %)
0 diff
(100 %id)
BM769226 stomach .i 88 to 556 1 to 469       469/469
(100 %)
0 diff
(100 %id)
BQ084533 stomach .i 88 to 456 1 to 369       369/369
(100 %)
0 diff
(100 %id)
CB141820 Liver .i 91 to 443 1 to 353       353/353
(100 %)
0 diff
(100 %id)
AJ131182 brain .i 93 to 1197 14 to 1118 T117I AAA   1105/1118
(98 %)
8 diff
(99.3 %id)
CD673789 eye, lens .i 93 to 631 1 to 539       539/539
(100 %)
0 diff
(100 %id)
BF342150 brain, glioblastoma with EGFR amplification .i 93 to 869 1 to 775       775/963
(80 %)
14 diff
(98.6 %id)
BG680266 skin, squamous cell carcinoma .i 93 to 971 1 to 877       877/877
(100 %)
3 diff
(99.7 %id)
CF126413 Chondrosarcoma Lung Metastasis cell lines, lung .i 93 to 681 1 to 589       589/589
(100 %)
0 diff
(100 %id)
TI_154189400   .i 93 to 1001 51 to 950       900/1036
(86 %)
22 diff
(97.9 %id)
BI826452 brain, medulla .i 94 to 927 1 to 832       832/875
(95 %)
6 diff
(99.4 %id)
CA489097   .i 94 to 966 1 to 878       878/887
(98 %)
20 diff
(97.8 %id)
BM844296 lymph node, stomach .i 94 to 463 1 to 370       370/370
(100 %)
0 diff
(100 %id)
BM842638 lymph node, stomach .i 94 to 631 1 to 538       538/538
(100 %)
0 diff
(100 %id)
BM844675 lymph node, stomach .i 94 to 600 1 to 507       507/507
(100 %)
0 diff
(100 %id)
BM846442 lymph node, stomach .i 94 to 627 1 to 534       534/534
(100 %)
0 diff
(100 %id)
CR597570 Neuroblastoma Cot 25-normalized .i 99 to 1170 1 to 1072 exact     1072/1072
(100 %)
0 diff
(100 %id)
CR606967 Neuroblastoma Cot 10-normalized .i 99 to 1195 1 to 1097 exact     1097/1097
(100 %)
0 diff
(100 %id)
AL524869 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .i 99 to 1169 1 to 1060 Q39H R40G V41* fully sequenced,   1060/1060
(100 %)
21 diff
(98.1 %id)
AL522807 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .i 100 to 595 1 to 497   fully sequenced,   495/495
(100 %)
4 diff
(99.2 %id)
BQ082796 stomach .i 100 to 618 26 to 544       519/519
(100 %)
0 diff
(100 %id)
BU184628 melanotic melanoma, cell line, skin .i 101 to 1004 1 to 907       907/908
(99 %)
10 diff
(98.9 %id)
BM794754 Ascites, stomach .i 102 to 761 1 to 660       660/660
(100 %)
1 diff
(99.9 %id)
BM854737 Ascites, stomach .i 102 to 600 1 to 499       499/499
(100 %)
0 diff
(100 %id)
AL136928 uterus .i 103 to 1212 1 to 1110 exact available from DKFZ, AAA   1110/1110
(100 %)
2 diff
(99.9 %id)
BC007250 Lymph, Burkitt lymphoma .i 103 to 1212 1 to 1110 exact available from MGC, AAA   1110/1110
(100 %)
2 diff
(99.9 %id)
BI818385 pooled brain, lung, testis .i 103 to 874 1 to 775       775/777
(99 %)
5 diff
(99.4 %id)
CN408527 embryonic stem cells, cell lines H1, H7, andH9 .i 104 to 804 1 to 702       702/702
(100 %)
1 diff
(99.9 %id)
BM562603 amelanotic melanoma, cell line, skin .i 104 to 976 1 to 881       881/1021
(86 %)
26 diff
(97.5 %id)
BG749409 eye, normal pigmented retinal epithelium .i 105 to 920 1 to 815       815/816
(99 %)
6 diff
(99.3 %id)
BI224881 Burkitt lymphoma, lymph .i 105 to 516 1 to 412       412/412
(100 %)
0 diff
(100 %id)
BI226122 Burkitt lymphoma, lymph .i 105 to 808 1 to 704       704/706
(99 %)
2 diff
(99.8 %id)
BQ883219 eye, normal pigmented retinal epithelium .i 105 to 747 1 to 647       647/1039
(62 %)
5 diff
(99.6 %id)
CD623987   .i 106 to 841 1 to 735       735/747
(98 %)
5 diff
(99.4 %id)
CR614136 T cells (Jurkat cell line) Cot10-normalized .i 106 to 1160 1 to 1055 exact     1055/1055
(100 %)
0 diff
(100 %id)
BG698529 skin .i 106 to 830 1 to 723       723/723
(100 %)
8 diff
(98.9 %id)
AJ249366   .i 107 to 1197 1 to 1092 exact AAA   1092/1092
(100 %)
3 diff
(99.8 %id)
CR590464 B cells (Ramos cell line) Cot 25-normalized .i 107 to 1179 1 to 1073 exact     1073/1073
(100 %)
0 diff
(100 %id)
CR612998 neuroblastoma .i 107 to 1211 1 to 1105 exact     1105/1105
(100 %)
0 diff
(100 %id)
CR614529 T cells (Jurkat cell line) Cot10-normalized .i 107 to 1163 1 to 1057 exact     1057/1057
(100 %)
0 diff
(100 %id)
BQ058868 lymph, lymphoma, cell line .i 107 to 1123 1 to 1026 T117I A235X E236*     1026/1062
(96 %)
12 diff
(98.9 %id)
BQ053949 blood, natural killer cells, cell line .i 107 to 1005 1 to 909       908/1070
(84 %)
24 diff
(97.8 %id)
BC003155 Skin, melanotic melanoma. .i 108 to 1200 1 to 1093 exact available from MGC, AAA   1093/1093
(100 %)
4 diff
(99.7 %id)
BG679547 skin, squamous cell carcinoma .i 108 to 992 1 to 888       888/889
(99 %)
5 diff
(99.5 %id)
BQ227388 embryonal carcinoma, cell line, testis .i 108 to 1001 1 to 894       894/896
(99 %)
4 diff
(99.6 %id)
BQ950009 epidermoid carcinoma, cell line, lung .i 108 to 971 1 to 865       865/866
(99 %)
10 diff
(98.9 %id)
CF128343 Chondrosarcoma Lung Metastasis cell lines, lung .i 108 to 778 1 to 671       671/671
(100 %)
0 diff
(100 %id)
TI_59386421   .i 108 to 1000 92 to 980       889/911
(97 %)
18 diff
(98.1 %id)
BM794720 Ascites, stomach .i 108 to 783 1 to 676       676/676
(100 %)
0 diff
(100 %id)
BM824771 Ascites, stomach .i 108 to 696 1 to 589       589/589
(100 %)
0 diff
(100 %id)
CR607034 Placenta Cot 25-normalized .i 109 to 1159 1 to 1051 exact     1051/1051
(100 %)
0 diff
(100 %id)
CR614039 Neuroblastoma Cot 50-normalized .i 109 to 1213 1 to 1105 exact     1105/1105
(100 %)
0 diff
(100 %id)
BQ651864 hepatocellular carcinoma, cell line, Liver .i 109 to 869 1 to 762       762/937
(81 %)
22 diff
(97.7 %id)
BU846488 ovary, teratocarcinoma, cell line .i 109 to 793 1 to 687       687/824
(83 %)
9 diff
(99.0 %id)
BU557147 ovary, teratocarcinoma, cell line .i 109 to 921 1 to 813       813/864
(94 %)
2 diff
(99.8 %id)
BU196499 melanotic melanoma, cell line, skin .i 110 to 926 1 to 821       821/927
(88 %)
17 diff
(98.2 %id)
BU849879 ovary, teratocarcinoma, cell line .i 110 to 1025 1 to 918       918/920
(99 %)
27 diff
(97.1 %id)
BM762636 lymph node, stomach .i 110 to 745 1 to 636       636/636
(100 %)
0 diff
(100 %id)
BM842056 lymph node, stomach .i 110 to 678 1 to 569       569/569
(100 %)
0 diff
(100 %id)
BM842798 lymph node, stomach .i 110 to 669 1 to 560       560/560
(100 %)
0 diff
(100 %id)
BM843206 lymph node, stomach .i 110 to 637 1 to 528       528/528
(100 %)
0 diff
(100 %id)
BM850171 lymph node, stomach .i 110 to 674 1 to 565       565/565
(100 %)
0 diff
(100 %id)
BM845687 lymph node, stomach .i 110 to 599 1 to 490       490/490
(100 %)
0 diff
(100 %id)
TI_154192895   .i 110 to 927 50 to 867       818/994
(82 %)
10 diff
(99.0 %id)
TI_154193139   .i 110 to 927 50 to 866       817/1014
(80 %)
8 diff
(99.3 %id)
TI_154193215   .i 110 to 919 50 to 860       811/889
(91 %)
18 diff
(98.0 %id)
TI_154194621   .i 110 to 927 46 to 859   AAA   814/1022
(79 %)
14 diff
(98.7 %id)
BM723933 eye, fetal eye .i 110 to 731 1 to 622   fully sequenced,   622/622
(100 %)
0 diff
(100 %id)
CN408519 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .i 111 to 832 1 to 722       722/722
(100 %)
0 diff
(100 %id)
BI517583 pooled colon, kidney, stomach .i 111 to 503 1 to 393   fully sequenced,   393/393
(100 %)
0 diff
(100 %id)
BM460529 leiomyosarcoma, uterus .i 111 to 1148 1 to 1049 Q240P K245Q I257L S260F K265R ...     1049/1058
(99 %)
59 diff
(94.5 %id)
BM542497 embryonal carcinoma, cell line, testis .i 111 to 1004 1 to 899       899/1071
(83 %)
34 diff
(96.9 %id)
CF127595 Chondrosarcoma Lung Metastasis cell lines, lung .i 111 to 785 1 to 675       675/675
(100 %)
0 diff
(100 %id)
CF127478 Chondrosarcoma Lung Metastasis cell lines, lung .i 111 to 785 1 to 675       675/675
(100 %)
0 diff
(100 %id)
CF131162 Chondrosarcoma Lung Metastasis cell lines, lung .i 111 to 785 1 to 675       675/675
(100 %)
2 diff
(99.8 %id)
BQ053524 blood, natural killer cells, cell line .i 112 to 1001 1 to 901       899/1045
(86 %)
14 diff
(98.7 %id)
CF126374 Chondrosarcoma Lung Metastasis cell lines, lung .i 112 to 868 1 to 757       757/757
(100 %)
4 diff
(99.5 %id)
TI_59382670   .i 112 to 831 96 to 815       720/722
(99 %)
4 diff
(99.5 %id)
BM824906 Ascites, stomach .i 112 to 347 1 to 236       236/236
(100 %)
0 diff
(100 %id)
TI_154189353   .i 112 to 991 51 to 919       869/1001
(86 %)
25 diff
(97.6 %id)
BU857822 adenocarcinoma, cell line, breast .i 113 to 993 1 to 889       887/911
(97 %)
15 diff
(98.4 %id)
BM724101 eye, fetal eye .i 113 to 649 1 to 537   fully sequenced,   537/537
(100 %)
1 diff
(99.9 %id)
CN408542 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .i 114 to 495 1 to 382       382/382
(100 %)
0 diff
(100 %id)
CR593512 Neuroblastoma Cot 50-normalized .i 115 to 1162 1 to 1048 exact     1048/1048
(100 %)
0 diff
(100 %id)
CR608364 Placenta Cot 25-normalized .i 115 to 1185 1 to 1071 exact     1071/1071
(100 %)
0 diff
(100 %id)
CR612461 Neuroblastoma Cot 25-normalized .i 115 to 1154 1 to 1040 exact     1040/1040
(100 %)
0 diff
(100 %id)
AL547965 placenta, Placenta Cot 25-normalized .i 115 to 1177 1 to 1049 Q39X R40G V41* fully sequenced,   1049/1049
(100 %)
31 diff
(97.1 %id)
BG677919 skin, squamous cell carcinoma .i 115 to 998 1 to 895       891/1062
(83 %)
19 diff
(98.3 %id)
BP214411 corpus callosum .i 116 to 697 1 to 582       582/582
(100 %)
0 diff
(100 %id)
CN408539 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .i 116 to 314 1 to 199       199/199
(100 %)
0 diff
(100 %id)
CF128281 Chondrosarcoma Lung Metastasis cell lines, lung .i 116 to 785 1 to 670       670/670
(100 %)
0 diff
(100 %id)
TI_154194134   .i 116 to 1087 51 to 1021 A224G A234G Q240X I257X V258R ...     971/1066
(91 %)
19 diff
(98.3 %id)
BC017285 Brain, neuroblastoma .i 117 to 1197 1 to 1081 exact available from MGC, AAA   1081/1081
(100 %)
2 diff
(99.9 %id)
CN408521 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .i 117 to 832 1 to 716       716/716
(100 %)
2 diff
(99.8 %id)
CR609957 Neuroblastoma Cot 50-normalized .i 117 to 1189 1 to 1073 exact     1073/1073
(100 %)
0 diff
(100 %id)
CR610901 Neuroblastoma Cot 50-normalized .i 117 to 1193 1 to 1077 exact     1077/1077
(100 %)
0 diff
(100 %id)
CR619382 T cells (Jurkat cell line) Cot10-normalized .i 117 to 1211 1 to 1095 exact     1095/1095
(100 %)
0 diff
(100 %id)
BG034888 adenocarcinoma, cell line, Liver .i 117 to 815 1 to 697       697/697
(100 %)
4 diff
(99.5 %id)
BM806190 leiomyosarcoma, uterus .i 117 to 1120 1 to 1006 E268W V269S T270D N271K R272P ...     1004/1061
(94 %)
15 diff
(98.6 %id)
BU849709 ovary, teratocarcinoma, cell line .i 117 to 995 1 to 880       880/886
(99 %)
3 diff
(99.7 %id)
BM855165 Ascites, stomach .i 117 to 618 1 to 502       502/502
(100 %)
0 diff
(100 %id)
BF036116 adenocarcinoma, ovary .i 118 to 822 1 to 704       704/705
(99 %)
7 diff
(99.1 %id)
BQ067462 pooled brain, lung, testis .i 118 to 921 1 to 815       815/1079
(75 %)
15 diff
(98.7 %id)
BQ052084 blood, natural killer cells, cell line .i 118 to 997 1 to 885       885/1074
(82 %)
19 diff
(98.3 %id)
BQ052374 blood, natural killer cells, cell line .i 118 to 1004 1 to 895       895/1094
(81 %)
30 diff
(97.3 %id)
BU931980 ovary, teratocarcinoma, cell line .i 118 to 1030 1 to 918       913/918
(99 %)
15 diff
(98.4 %id)
CN408528 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .i 120 to 679 1 to 560       560/560
(100 %)
0 diff
(100 %id)
BM769207 stomach .i 120 to 487 1 to 368       368/368
(100 %)
0 diff
(100 %id)
BM769257 stomach .i 120 to 306 1 to 187       187/187
(100 %)
0 diff
(100 %id)
BM769768 stomach .i 120 to 671 1 to 552       552/552
(100 %)
0 diff
(100 %id)
BY795675 eye .i 121 to 780 1 to 660       660/660
(100 %)
0 diff
(100 %id)
CR456886   .i 122 to 1044 1 to 923       923/927
(99 %)
1 diff
(99.9 %id)
BE744476 adenocarcinoma cell line, ovary .i 122 to 927 1 to 806       806/948
(85 %)
10 diff
(99.0 %id)
BI827739 brain, medulla .i 122 to 817 1 to 696       696/696
(100 %)
2 diff
(99.8 %id)
BE561217 Burkitt lymphoma, lymph .i 125 to 927 1 to 798       798/922
(86 %)
14 diff
(98.5 %id)
BM704739 eye, RPE and Choroid .i 126 to 832 1 to 707       707/707
(100 %)
1 diff
(99.9 %id)
CN408549 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .i 131 to 440 1 to 310       310/310
(100 %)
0 diff
(100 %id)
BQ225440 epithelioid carcinoma, Pancreas .i 131 to 983 1 to 862       859/874
(98 %)
21 diff
(97.6 %id)
BE514708 adenocarcinoma cell line, ovary .i 135 to 809 1 to 673       673/678
(99 %)
9 diff
(98.7 %id)
BQ682605 melanotic melanoma, cell line, skin .i 142 to 971 1 to 832       832/833
(99 %)
6 diff
(99.3 %id)
BQ684036 melanotic melanoma, cell line, skin .i 146 to 857 1 to 714       714/888
(80 %)
8 diff
(99.1 %id)
CR613779 Placenta Cot 25-normalized .i 166 to 1161 1 to 996       996/996
(100 %)
0 diff
(100 %id)
CN408525 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .i 185 to 738 1 to 554       554/554
(100 %)
0 diff
(100 %id)
CF130810 Chondrosarcoma Lung Metastasis cell lines, lung .i 189 to 925 1 to 737       737/737
(100 %)
1 diff
(99.9 %id)
CR607244 Placenta Cot 25-normalized .i 246 to 1213 1 to 968       968/968
(100 %)
0 diff
(100 %id)
AL551795 placenta, Placenta Cot 25-normalized .i 246 to 1213 1 to 966   fully sequenced,   966/966
(100 %)
3 diff
(99.7 %id)
BM825027 Ascites, stomach .i 276 to 806 1 to 531       531/531
(100 %)
0 diff
(100 %id)
TI_149302801   .i 302 to 1212 958 to 53   AAA   906/986
(91 %)
8 diff
(99.2 %id)
TI_149298814   .i 307 to 1212 994 to 93   AAA   902/978
(92 %)
10 diff
(99.0 %id)
TI_149303312   .i 311 to 1212 981 to 82   AAA   900/961
(93 %)
12 diff
(98.8 %id)
CA488192   .i 317 to 1155 1 to 846       846/915
(92 %)
21 diff
(97.8 %id)
TI_154115303   .i 326 to 1197 947 to 88   AAA   860/979
(87 %)
18 diff
(98.2 %id)
TI_149297775   .i 425 to 1207 862 to 88   AAA   775/962
(80 %)
8 diff
(99.2 %id)
CN408553 embryonic stem cells, DMSO-treated H9 cellline .i 465 to 677 1 to 213       213/213
(100 %)
0 diff
(100 %id)
BI518122 pooled colon, kidney, stomach .i 473 to 1139 694 to 25   fully sequenced,   670/694
(96 %)
1 diff
(99.9 %id)
CB851002 lung, Primary Lung Cystic Fibrosis EpithelialCells .i 492 to 1212 739 to 19   AAA   721/721
(100 %)
0 diff
(100 %id)
CA420385 Bone, Enchondroma cell line .i 496 to 1197 720 to 19   AAA   702/702
(100 %)
0 diff
(100 %id)
BM690502 eye, RPE and Choroid .i 499 to 1150 9 to 658       650/658
(98 %)
4 diff
(99.4 %id)
BM982786 lung, Primary Lung Cystic Fibrosis EpithelialCells .i 504 to 1207 722 to 19   AAA   704/704
(100 %)
0 diff
(100 %id)
BM975501 lung, Primary Lung Cystic Fibrosis EpithelialCells .i 504 to 1212 727 to 19   AAA   709/709
(100 %)
0 diff
(100 %id)
CA449058 Chondrosarcoma, Left Pubic Bone .i 504 to 1197 712 to 19   AAA   694/694
(100 %)
1 diff
(99.9 %id)
CD369265 Alveolar Macrophage, lung .i 504 to 1212 727 to 19   AAA   709/709
(100 %)
0 diff
(100 %id)
BM981346 lung, Primary Lung Cystic Fibrosis EpithelialCells .i 505 to 1212 726 to 19   AAA   708/708
(100 %)
0 diff
(100 %id)
AL522806 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .i 534 to 1195 660 to 1   fully sequenced,   660/660
(100 %)
4 diff
(99.4 %id)
AL524868 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .i 534 to 1151 617 to 1   fully sequenced,   617/617
(100 %)
9 diff
(98.6 %id)
AL572712 placenta, Placenta Cot 25-normalized .i 534 to 1185 652 to 1   fully sequenced,   652/652
(100 %)
2 diff
(99.7 %id)
BQ007573 Chondrosarcoma, Left Pubic Bone .i 548 to 1212 683 to 19   AAA   665/666
(99 %)
0 diff
(100 %id)
BU627722 Bone, Enchondroma cell line .i 553 to 1212 678 to 19   AAA   660/660
(100 %)
0 diff
(100 %id)
BQ018237 lung, Metastatic Chondrosarcoma .i 561 to 1197 655 to 19   AAA   637/637
(100 %)
5 diff
(99.3 %id)
BM669804 eye, fetal eyes .i 587 to 1197 629 to 19   AAA   611/611
(100 %)
1 diff
(99.9 %id)
AL575278 placenta, Placenta Cot 25-normalized .i 588 to 1178 591 to 1   fully sequenced,   591/591
(100 %)
2 diff
(99.7 %id)
BM680289 eye, fetal eye .i 588 to 1212 643 to 19   fully sequenced, AAA   625/625
(100 %)
1 diff
(99.9 %id)
BU539676 adenocarcinoma, cell line, breast .i 613 to 1212 1 to 600   AAA   600/600
(100 %)
0 diff
(100 %id)
BQ279105 adenocarcinoma, cell line, breast .i 647 to 1212 1 to 566   AAA   566/566
(100 %)
0 diff
(100 %id)
BM680081 eye, fetal eye .i 670 to 1197 546 to 19   fully sequenced, AAA   528/528
(100 %)
1 diff
(99.9 %id)
EC523489 Prostate .i 732 to 816 85 to 1       85/85
(100 %)
0 diff
(100 %id)
BQ029235 lung, Metastatic Chondrosarcoma .i 738 to 1197 478 to 19   AAA   460/460
(100 %)
0 diff
(100 %id)
BU736787 eye, RPE and Choroid .i 738 to 1212 493 to 19   AAA   475/475
(100 %)
0 diff
(100 %id)
DB358444 whole embryo, mainly head .i 758 to 1212 466 to 14   fully sequenced, AAA   453/453
(100 %)
3 diff
(99.4 %id)
DB370425   .i 773 to 1212 442 to 1   fully sequenced,   442/442
(100 %)
2 diff
(99.6 %id)
EC500043 Prostate .i 929 to 1033 1 to 105       105/105
(100 %)
0 diff
(100 %id)
BM818222 stomach .i 932 to 1212 1 to 281   AAA   281/281
(100 %)
0 diff
(100 %id)
BM694816 eye, RPE and Choroid .i 934 to 1213 1 to 280   fully sequenced,   280/280
(100 %)
0 diff
(100 %id)
BX401649   .i 951 to 1213 1 to 263       263/263
(100 %)
0 diff
(100 %id)
EC469749 Prostate .i 957 to 1056 1 to 100       100/100
(100 %)
0 diff
(100 %id)
CA748882 Bone, Subchondral Bone .i 1001 to 1212 231 to 19   AAA   213/213
(100 %)
0 diff
(100 %id)
EC489650 Prostate .i 1005 to 1097 1 to 93       93/93
(100 %)
0 diff
(100 %id)
AI459119 pooled .i 1063 to 1211 149 to 1       149/149
(100 %)
0 diff
(100 %id)
BU731629 eye, RPE and Choroid .i 1092 to 1212 139 to 19   fully sequenced, AAA   121/121
(100 %)
0 diff
(100 %id)
BG481377 choriocarcinoma, placenta .j 1 to 805 1 to 805   tiling clone,   805/805
(100 %)
5 diff
(99.4 %id)
BG334206 melanotic melanoma, skin .j 9 to 664 1 to 661   tiling clone,   661/873
(75 %)
24 diff
(97.3 %id)
BU853683 testis .j 468 to 1091 1 to 632   tiling clone, AAA   632/632
(100 %)
18 diff
(97.2 %id)
AL134640 brain .k 1 to 555 1 to 555   tiling clone,   555/555
(100 %)
0 diff
(100 %id)
AA039433 heart .k 251 to 522 1 to 278       278/345
(80 %)
11 diff
(96.9 %id)
AA039434 heart .k 1192 to 1615 435 to 1   tiling clone,   435/466
(93 %)
27 diff
(94.3 %id)
CB996278 placenta, pre-eclamptic placenta .l 1 to 720 26 to 747   tiling clone,   725/761
(95 %)
17 diff
(97.8 %id)
BQ448422 Knee, Osteoarthritic Cartilage .l 687 to 1119 451 to 19   tiling clone, AAA   433/433
(100 %)
2 diff
(99.6 %id)
BQ051628 blood, natural killer cells, cell line .m 1 to 787 1 to 793 L241P K242E D243G A244M H245P ... tiling clone,   793/917
(86 %)
11 diff
(98.9 %id)
BQ054019 blood, natural killer cells, cell line .m 1 to 643 12 to 657   tiling clone,   644/1189
(54 %)
16 diff
(98.7 %id)
NM_199442.1   .n 1 to 978 4 to 981 exact RefSeq,   981/981
(100 %)
0 diff
(100 %id)
CD247793 embryonic stem cells, WA01, passage 38 .n 1 to 869 23 to 893 Q178* tiling clone,   869/898
(96 %)
16 diff
(98.3 %id)
DB276556.
matches multiple genes
uterus .n 14 to 543 2 to 531   capped also hits gene PLXNB1 530/530
(100 %)
1 diff
(99.9 %id)
BG106562 lymph, lymphoma, cell line .n 15 to 692 1 to 682       682/1007
(67 %)
22 diff
(97.9 %id)
BM808839 amelanotic melanoma, cell line, skin .n 20 to 963 1 to 958 E217* tiling clone,   958/1072
(89 %)
36 diff
(96.7 %id)
BM792021 Ascites, stomach .n 23 to 550 1 to 528       528/528
(100 %)
0 diff
(100 %id)
BQ432055 eye, retinoblastoma .n 24 to 882 11 to 872 N169H Q178X Q189X N220T L223C ... tiling clone,   860/878
(97 %)
29 diff
(96.7 %id)
BG281001 melanotic melanoma, skin .n 28 to 803 1 to 774       774/774
(100 %)
18 diff
(97.7 %id)
CN408531 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .n 31 to 700 1 to 672       672/674
(99 %)
9 diff
(98.7 %id)
BP212869 cerebrum .n 34 to 610 1 to 576       576/576
(100 %)
3 diff
(99.5 %id)
CN408538 embryonic stem cells, cell lines H1, H7, andH9 .n 34 to 706 1 to 676       676/676
(100 %)
2 diff
(99.8 %id)
BM794656 Ascites, stomach .n 103 to 786 1 to 684   tiling clone,   684/684
(100 %)
0 diff
(100 %id)
BG529211 embryonal carcinoma, testis .o 1 to 689 9 to 700   tiling clone,   700/801
(87 %)
16 diff
(98.1 %id)
NM_199444.1   .o 1 to 975 4 to 978 exact RefSeq,   978/978
(100 %)
0 diff
(100 %id)
CF619034 Pooled Chondrosarcoma Tumor cells .o 1 to 738 20 to 769       747/918
(81 %)
28 diff
(97.0 %id)
CF619033 Pooled Chondrosarcoma Tumor cells .o 1 to 748 20 to 773       751/892
(84 %)
22 diff
(97.6 %id)
BF697912 brain, primitive neuroectoderm .o 15 to 689 1 to 671       671/721
(93 %)
12 diff
(98.4 %id)
AA205346   .o 20 to 446 1 to 426   fully sequenced,   426/426
(100 %)
10 diff
(97.7 %id)
BI835988 pooled pancreas and spleen .o 24 to 780 1 to 757       757/762
(99 %)
6 diff
(99.3 %id)
TI_57164702   .o 24 to 780 70 to 826       755/831
(90 %)
11 diff
(98.7 %id)
BM454494 embryonal carcinoma, cell line, testis .o 25 to 952 1 to 938 exact AAA   938/967
(97 %)
16 diff
(98.4 %id)
BG397013 melanotic melanoma, skin .o 27 to 838 1 to 807 D144T S145A L146W E147S C148A ...     807/816
(98 %)
19 diff
(97.7 %id)
BF338124 brain, glioblastoma with EGFR amplification .o 28 to 827 13 to 805 D144T S145A L146W E147S C148A ...     791/826
(95 %)
22 diff
(97.4 %id)
CR976404 T-Lymphocytes .o 33 to 925 1 to 894 exact     894/894
(100 %)
5 diff
(99.5 %id)
N42234 placenta .o 95 to 469 1 to 374       374/375
(99 %)
9 diff
(97.6 %id)
BU196580 melanotic melanoma, cell line, skin .o 252 to 982 1 to 734   tiling clone,   734/926
(79 %)
6 diff
(99.4 %id)
AA205564   .o 427 to 956 521 to 1   fully sequenced,   521/521
(100 %)
16 diff
(97.0 %id)
N32793 placenta .o 587 to 969 380 to 1       380/383
(99 %)
15 diff
(96.1 %id)
BM706526 eye, eye anterior segment .o 639 to 970 1 to 332   tiling clone, fully sequenced,   332/332
(100 %)
1 diff
(99.7 %id)
CR742687 breast .o 640 to 967 1 to 328       328/328
(100 %)
0 diff
(100 %id)
BM694136 eye, RPE and Choroid .o 643 to 959 1 to 317       317/317
(100 %)
0 diff
(100 %id)
BM673053 eye, eye anterior segment .o 895 to 976 93 to 12   fully sequenced,   82/93
(88 %)
5 diff
(94.7 %id)
BG339929 leiomyosarcoma cell line, uterus .p 1 to 648 1 to 641   tiling clone,   641/1060
(60 %)
13 diff
(98.8 %id)
DR158665 human embryonic stem cells differentiated toan early endodermal cell type .p 4 to 754 1 to 751 E238X N242K tiling clone,   751/751
(100 %)
1 diff
(99.9 %id)
DT220675 brain .q 1 to 674 2 to 674   tiling clone,   674/674
(100 %)
1 diff
(99.9 %id)
DA057992 cerebellum .q 1 to 577 2 to 578   tiling clone, capped   577/577
(100 %)
1 diff
(99.9 %id)
AY927479   .q 539 to 1223 686 to 2   tiling clone, Submitted on the opposite strand 685/686
(99 %)
2 diff
(99.8 %id)
AI905657 breast .q 958 to 1151 24 to 222       199/224
(88 %)
13 diff
(94.2 %id)
BE710313 head_neck .q 958 to 1204 252 to 7       246/258
(95 %)
4 diff
(98.5 %id)
AW374217 breast .q 967 to 1079 128 to 15       114/137
(83 %)
0 diff
(100 %id)
BI522043 pooled pancreas and spleen .q 1162 to 1822 700 to 26   tiling clone,   675/876
(77 %)
31 diff
(96.5 %id)
CR986690 T-Lymphocytes .r 1 to 773 1 to 775 exact tiling clone,   775/775
(100 %)
4 diff
(99.5 %id)
TI_154193228   .r 3 to 763 49 to 803 E147Q K170X D178G A179C L181S ... tiling clone,   755/865
(87 %)
21 diff
(97.6 %id)
AI073973 B-cell, chronic lymphotic leukemia .s 1 to 593 609 to 18 P2T R3L P4A L20S T21P ... tiling clone, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 592/689
(85 %)
8 diff
(98.9 %id)
TI_157609773   .s 40 to 586 650 to 104   tiling clone, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 547/650
(84 %)
2 diff
(99.7 %id)
BQ011147 placenta .s 144 to 586 461 to 19   tiling clone, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 443/461
(96 %)
2 diff
(99.6 %id)
CF530013 placenta .s 146 to 586 459 to 19   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 441/459
(96 %)
1 diff
(99.8 %id)
BM768349 stomach .s 333 to 593 1 to 261   tiling clone, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 261/271
(96 %)
1 diff
(99.7 %id)
BQ712727 Spleen .t-u 1 to 711 1 to 713   tiling clone,   713/932
(76 %)
7 diff
(99.3 %id)
DA111535 cerebellum .t-u 100 to 686 2 to 588   tiling clone, capped   587/587
(100 %)
0 diff
(100 %id)
BI912056 leukocyte .t-u 311 to 1024 17 to 733       717/902
(79 %)
8 diff
(99.2 %id)
TI_57236659   .t-u 311 to 1024 17 to 733       717/902
(79 %)
8 diff
(99.2 %id)
BI906554 leukocyte .t-u 432 to 1079 1 to 647   tiling clone,   647/647
(100 %)
3 diff
(99.6 %id)
TI_57232932   .t-u 432 to 1079 30 to 676       647/676
(95 %)
6 diff
(99.2 %id)
BI059805 uterus_tumor .t-u 515 to 691 178 to 1       178/196
(90 %)
13 diff
(93.4 %id)
CD517270 White Matter .t-u 733 to 1511 27 to 813 P129S T148N A156V S159L G168R ... tiling clone,   787/874
(90 %)
24 diff
(97.3 %id)
CF137240 lymph .t-u 1098 to 1291 1 to 194   tiling clone,   194/194
(100 %)
5 diff
(97.5 %id)
BU163757 epidermoid carcinoma, cell line, salivary gland .u 1 to 962 1 to 960   tiling clone,   960/961
(99 %)
17 diff
(98.3 %id)
CV570035 cornea, eye .va 1 to 581 1 to 581 exact tiling clone,   581/581
(100 %)
0 diff
(100 %id)
BP350605   .vb 1 to 584 1 to 584   tiling clone,   584/584
(100 %)
1 diff
(99.9 %id)
DA693950   .vb 17 to 586 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
BP365123 lung .vb 17 to 597 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
DA074034 cerebellum .vb 18 to 596 2 to 580   capped   579/579
(100 %)
3 diff
(99.5 %id)
DB092670 testis .vb 18 to 569 2 to 553   capped   552/552
(100 %)
2 diff
(99.7 %id)
DB141524 thymus .vb 18 to 562 2 to 549   capped   548/548
(100 %)
4 diff
(99.3 %id)
DB194047 ovary, tumor tissue .vb 18 to 590 2 to 585   capped   582/584
(99 %)
14 diff
(97.7 %id)
BP289771 lung .vb 19 to 601 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
BG540162 lung .vb 20 to 734 1 to 718       718/889
(80 %)
30 diff
(96.7 %id)
DB108078 thymus .vb 20 to 600 2 to 582   capped   581/581
(100 %)
2 diff
(99.7 %id)
BP197675 adrenal gland .vb 24 to 607 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
BP197668 adrenal gland .vb 25 to 601 1 to 578       578/581
(99 %)
3 diff
(99.5 %id)
BP197683 adrenal gland .vb 25 to 608 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
TI_57165140   .vb 27 to 729 67 to 849       781/908
(86 %)
65 diff
(92.9 %id)
BP374110 umbilical cord .vb 34 to 608 1 to 578       578/578
(100 %)
7 diff
(98.8 %id)
DA316866 hippocampus .vb 35 to 459 2 to 426   capped   425/425
(100 %)
2 diff
(99.6 %id)
BP352890   .vb 50 to 630 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
CR981373 T-Lymphocytes .vb 118 to 731 1 to 615       615/617
(99 %)
3 diff
(99.6 %id)
CR604662 Placenta Cot 25-normalized .vb 180 to 1951 1 to 1772 exact tiling clone,   1772/1772
(100 %)
0 diff
(100 %id)
AL543290 placenta, Placenta Cot 25-normalized .vb 180 to 1077 1 to 892   fully sequenced,   890/890
(100 %)
4 diff
(99.6 %id)
AL569869 placenta, Placenta Cot 25-normalized .vb 1047 to 1951 890 to 1 K35X fully sequenced,   890/890
(100 %)
2 diff
(99.8 %id)
BP369851 testis .vb 1273 to 1849 1 to 577 exact     577/577
(100 %)
0 diff
(100 %id)
BI825529 brain, medulla .vb 1288 to 1988 1 to 703 A7C D8*     703/733
(95 %)
17 diff
(97.7 %id)
BM908068 brain, medulla .vb 1288 to 1989 19 to 721 exact     703/727
(96 %)
2 diff
(99.8 %id)
TI_57170420   .vb 1288 to 1988 60 to 762 A7C D8*     703/792
(88 %)
19 diff
(97.7 %id)
BM563452 brain, medulla .vb 1289 to 2003 1 to 715 exact     715/719
(99 %)
1 diff
(99.9 %id)
BI832276 brain, medulla .vb 1295 to 1849 28 to 582 A12S     555/582
(95 %)
6 diff
(99.0 %id)
TI_57176693   .vb 1295 to 1849 28 to 582 A12S     555/582
(95 %)
6 diff
(99.0 %id)
AA417116.
matches multiple genes
  .vb 1297 to 1791 1 to 496     also hits gene LOC344595 496/522
(95 %)
7 diff
(98.7 %id)
AA397788   .vb 1299 to 1697 1 to 399   fully sequenced,   399/399
(100 %)
1 diff
(99.8 %id)
BQ182571 Knee, Osteoarthritic Cartilage .vb 1477 to 2006 548 to 19   tiling clone, AAA   530/530
(100 %)
0 diff
(100 %id)
CA308011 Alveolar Macrophage, lung .vb 1486 to 2003 536 to 19   AAA   518/518
(100 %)
0 diff
(100 %id)
DB517433 testis .vb 1532 to 1988 1 to 457     Submitted on the opposite strand 457/457
(100 %)
0 diff
(100 %id)
BM456894 embryonal carcinoma, cell line, testis .vb 1559 to 2003 1 to 445   AAA   445/445
(100 %)
0 diff
(100 %id)
AI751720 Bone, Hip .vb 1578 to 1995 426 to 9       418/426
(98 %)
1 diff
(99.8 %id)
AA757714 pineal gland .vb 1590 to 2004 444 to 31       414/460
(90 %)
13 diff
(97.2 %id)
AI817572 normal prostate, Prostate .vb 1606 to 2004 399 to 1       399/399
(100 %)
0 diff
(100 %id)
BM988752 lung, Lung Focal Fibrosis .vb 1628 to 2003 394 to 19   AAA   376/376
(100 %)
0 diff
(100 %id)
AA399535   .vb 1667 to 1988 322 to 1   fully sequenced,   322/322
(100 %)
2 diff
(99.4 %id)
BP213941 cerebrum .vc 1 to 578 1 to 577 exact tiling clone,   577/577
(100 %)
2 diff
(99.7 %id)
DT220436 brain .vd 1 to 654 1 to 654   tiling clone,   654/654
(100 %)
2 diff
(99.7 %id)
BE645013 pooled .vd 442 to 1120 686 to 9   tiling clone,   678/686
(98 %)
8 diff
(98.9 %id)
BG251209 adenocarcinoma, cell line, Liver .vd 644 to 1120 1 to 477   AAA   477/477
(100 %)
2 diff
(99.6 %id)
DB571551 hypothalamus .vd 649 to 1120 1 to 472     Submitted on the opposite strand 472/472
(100 %)
2 diff
(99.6 %id)
BG254792 adenocarcinoma, cell line, Prostate .vd 650 to 1120 1 to 471   tiling clone, AAA   471/471
(100 %)
1 diff
(99.8 %id)
AI366804   .vd 659 to 1120 468 to 7       462/468
(98 %)
0 diff
(100 %id)
BM700348 eye, lens .vd 669 to 1120 1 to 452   fully sequenced, AAA   452/452
(100 %)
1 diff
(99.8 %id)
BU737999 eye, lens .vd 685 to 1120 454 to 19   fully sequenced, AAA   436/436
(100 %)
1 diff
(99.8 %id)
AI022518 parathyroid gland, parathyroid tumor .vd 689 to 1120 446 to 18   AAA   429/429
(100 %)
8 diff
(98.2 %id)
N53375 multiple sclerosis lesions .vd 703 to 1120 419 to 1       419/424
(98 %)
13 diff
(97.0 %id)
CD365387 Alveolar Macrophage, lung .vd 726 to 1120 410 to 16   AAA   395/395
(100 %)
2 diff
(99.5 %id)
AA878015 pharynx, squamous cell carcinoma .vd 743 to 1091 348 to 1       348/348
(100 %)
7 diff
(98.0 %id)
AA147890   .vd 746 to 1120 375 to 2       374/375
(99 %)
0 diff
(100 %id)
BE812680 amnion_normal .vd 763 to 1091 15 to 351       337/351
(96 %)
6 diff
(98.3 %id)
AI470489 pooled .vd 771 to 1120 351 to 1       351/352
(99 %)
8 diff
(97.8 %id)
CN284196 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .vd 797 to 1122 9 to 334   AAA   326/334
(97 %)
6 diff
(98.3 %id)
BY799338 eye .vd 801 to 1122 1 to 322   tiling clone,   322/323
(99 %)
2 diff
(99.4 %id)
AI245738 Kidney .vd 821 to 1122 303 to 2       302/303
(99 %)
0 diff
(100 %id)
BU589705 mixed (pool of 40 RNAs) .vd 830 to 1120 1 to 291   AAA   291/291
(100 %)
2 diff
(99.4 %id)
BF686745 leiomyosarcoma cell line, uterus .vd 833 to 1120 1 to 288   AAA   288/288
(100 %)
1 diff
(99.7 %id)
BG338299 leiomyosarcoma cell line, uterus .vd 833 to 1120 1 to 288   AAA   288/288
(100 %)
1 diff
(99.7 %id)
AW082553 esophagus, squamous cell carcinoma .vd 868 to 1120 261 to 8       254/261
(97 %)
0 diff
(100 %id)
AW084304 esophagus, squamous cell carcinoma .vd 868 to 1120 254 to 2       253/254
(99 %)
0 diff
(100 %id)
R49715 whole brain .vd 871 to 1120 262 to 13   AAA   250/270
(92 %)
1 diff
(99.7 %id)
AA505569 breast .vd 871 to 1119 249 to 1       249/249
(100 %)
0 diff
(100 %id)
AI269998 esophagus, squamous cell carcinoma .vd 883 to 1120 259 to 20   AAA   240/240
(100 %)
4 diff
(98.4 %id)
BF344191 brain, glioblastoma with EGFR amplification .vd 891 to 1120 1 to 228   AAA   228/228
(100 %)
2 diff
(99.2 %id)
AI586943 brain, tumor, 5 pooled (see description) .vd 918 to 1120 210 to 7       204/210
(97 %)
0 diff
(100 %id)
CA976015 sciatic nerve .vd 930 to 1120 1 to 191   AAA   191/191
(100 %)
0 diff
(100 %id)
BM915739 amelanotic melanoma, cell line, skin .ve 1 to 844 16 to 866 Q6E V123E S133R tiling clone,   851/1085
(78 %)
33 diff
(97.0 %id)
BM916823 amelanotic melanoma, cell line, skin .ve 2 to 601 66 to 672   tiling clone,   607/1380
(43 %)
35 diff
(97.5 %id)
BM554006 amelanotic melanoma, cell line, skin .ve 12 to 912 1 to 902 Q6E S133R tiling clone,   902/1057
(85 %)
12 diff
(98.9 %id)
BM561290 amelanotic melanoma, cell line, skin .ve 12 to 684 1 to 676 Q6E R125P Q128E S133Q L134V ...     676/1045
(64 %)
20 diff
(98.1 %id)
BM562046 amelanotic melanoma, cell line, skin .ve 12 to 603 1 to 595       595/1177
(50 %)
38 diff
(96.8 %id)
BM562201 amelanotic melanoma, cell line, skin .ve 12 to 804 1 to 802 Q6E S133R     802/1052
(76 %)
23 diff
(97.9 %id)
DB171898 kidney, tumor tissue .vf 1 to 583 2 to 584 T117I D144G tiling clone, capped   583/583
(100 %)
2 diff
(99.7 %id)
CR985793 T-Lymphocytes .vf 145 to 816 1 to 672   tiling clone,   672/672
(100 %)
5 diff
(99.3 %id)
BM711903 eye, human retina .vg 1 to 503 4 to 507 exact tiling clone, fully sequenced,   507/507
(100 %)
0 diff
(100 %id)
BM665706 eye, human retina .vg 442 to 813 389 to 19   tiling clone, fully sequenced, AAA   371/371
(100 %)
0 diff
(100 %id)
AY927480   .vh 1 to 584 585 to 2 T15A tiling clone, Submitted on the opposite strand 584/585
(99 %)
1 diff
(99.9 %id)
AI368030   .vi-u 1 to 382 1 to 382 P2S W4R G11V L13R S96R tiling clone, Submitted on the opposite strand 382/382
(100 %)
9 diff
(97.7 %id)
AI041957 senescent fibroblast .vi-u 157 to 588 438 to 6   tiling clone,   433/440
(98 %)
0 diff
(100 %id)
TI_57172094   .vj 1 to 876 20 to 885 A2G P3A P4S G7A P8R ... tiling clone,   866/885
(97 %)
26 diff
(97.1 %id)
BI831347 brain, medulla .vj 9 to 876 1 to 857 P4R A5P P6R G7P P8G ... tiling clone,   857/857
(100 %)
24 diff
(97.2 %id)
AA758138 pineal gland .vj 681 to 939 259 to 1   tiling clone,   259/259
(100 %)
1 diff
(99.7 %id)
AW451568   .vj 718 to 957 241 to 1   tiling clone,   241/242
(99 %)
5 diff
(98.0 %id)
CX166492 human embryonic stem cells differentiated toan early endodermal cell type .vk 1 to 733 1 to 733   tiling clone,   733/733
(100 %)
0 diff
(100 %id)
TI_57232744   .vl 1 to 789 25 to 820 exact tiling clone, AAA   796/952
(83 %)
15 diff
(98.5 %id)
BI906467 leukocyte .vl 11 to 789 1 to 786 exact     786/931
(84 %)
10 diff
(99.0 %id)
BQ708603 Spleen .vl 16 to 742 1 to 731 exact     731/950
(76 %)
14 diff
(98.6 %id)
AI791350 2 pooled tumors (clear cell type), Kidney .vl 282 to 795 514 to 1   tiling clone, Submitted on the opposite strand 514/518
(99 %)
1 diff
(99.9 %id)
BQ710530 Spleen .vm-u 1 to 766 1 to 766 Q86R E89K tiling clone,   766/944
(81 %)
10 diff
(99.0 %id)
CV355398 bocio_tumor .vm-u 248 to 590 28 to 368       341/378
(90 %)
3 diff
(99.3 %id)
AL045634 testis Gene HOMER3andCOPE, variant not shown              
AL045635 testis Gene HOMER3andCOPE, variant not shown       AAA      
EC496930 Prostate Gene HOMER3andCOPE, variant not shown              
184 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a-u, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t-u, .u, .va, .vb, .vc, .vd, .ve, .vf, .vg, .vh, .vi-u, .vj, .vk, .vl, .vm-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI